A PET for All Seasons: 18F-Fluorodeoxyglucose to Characterize Inflammation and Malignancy in Retroperitoneal Fibrosis?

Wolfgang P. Fendler; Matthias Eiber; Christian G. Stief; Ken Herrmann

doi:10.1016/j.eururo.2017.01.019

A PET for All Seasons: ¹⁸F-Fluorodeoxyglucose to Characterize Inflammation and Malignancy in Retroperitoneal Fibrosis?

Wolfgang P. Fendler, Matthias Eiber, Christian G. Stief, Ken Herrmann

Research output: Contribution to journal › Editorial

1 Scopus citations

Original language	English
Pages (from-to)	934-935
Number of pages	2
Journal	European Urology
Volume	71
Issue number	6
DOIs	https://doi.org/10.1016/j.eururo.2017.01.019
State	Published - Jun 2017
Externally published	Yes

Access to Document

10.1016/j.eururo.2017.01.019

Cite this

@article{624dfa07127843fc82aca3194b39197d,

title = "A PET for All Seasons: 18F-Fluorodeoxyglucose to Characterize Inflammation and Malignancy in Retroperitoneal Fibrosis?",

author = "Fendler, {Wolfgang P.} and Matthias Eiber and Stief, {Christian G.} and Ken Herrmann",

year = "2017",

month = jun,

doi = "10.1016/j.eururo.2017.01.019",

language = "English",

volume = "71",

pages = "934--935",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - A PET for All Seasons

T2 - 18F-Fluorodeoxyglucose to Characterize Inflammation and Malignancy in Retroperitoneal Fibrosis?

AU - Fendler, Wolfgang P.

AU - Eiber, Matthias

AU - Stief, Christian G.

AU - Herrmann, Ken

PY - 2017/6

Y1 - 2017/6

UR - http://www.scopus.com/inward/record.url?scp=85009726499&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2017.01.019

DO - 10.1016/j.eururo.2017.01.019

M3 - Editorial

C2 - 28111114

AN - SCOPUS:85009726499

SN - 0302-2838

VL - 71

SP - 934

EP - 935

JO - European Urology

JF - European Urology

IS - 6

ER -

A PET for All Seasons: 18F-Fluorodeoxyglucose to Characterize Inflammation and Malignancy in Retroperitoneal Fibrosis?

Access to Document

Other files and links

Cite this

A PET for All Seasons: ¹⁸F-Fluorodeoxyglucose to Characterize Inflammation and Malignancy in Retroperitoneal Fibrosis?